Observational Study of Patients Suffering From Endometriosis and Adenomyosis

checkorphan
Learn more about:
Adenomyosis
Related Clinical Trial
The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis Long-term Use of Mifepristone in the Treatment of Adenomyosis Radiofrequency Ablation of Adenomyosis Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis The Effect of Adenomoyosis on Pregnancy Outcomes Observational Study of Patients Suffering From Endometriosis and Adenomyosis Factors Associated With Adenomyosis and a Clinical Scoring System for the Diagnosis Quality of Life After Hysterectomy (AdenoQOL) Low Molecular Weight Heparin on the Adenomyosis Patients’IVF-ET Outcome Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI Clinical and Molecular Study of Endometriosis and Adenomyosis Surgical Success After Laparoscopic vs Abdominal Hysterectomy Electronic Catheter Stethoscope Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Uterine Artery Embolization for Symptomatic Fibroids Oxytocin in MRI-HIFU To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy Effect of Addition of Steroids on Duration of Analgesia Paracervical Block in Laparoscopic Hysterectomy Use of Dexamethasone in Uterine Artery Embolization Treatment of Benign Uterine Disorders Using High Intensity Focused Ultrasound (MR-HIFU) Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) Dienogest for Treatment of Adenomyotic Uteri Health-Related QoL Among Women Receiving Hysterectomy in NTUH Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis Adenomyosis and Ulipristal Acetate Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis LNG-IUS for Treatment of Dysmenorrhea Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis Adenomyosis: Genomic Mechanisms and Biological Response What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis A Prospective Study of Diagnostic Accuracy of Ultrasound Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis A Multi-omics Study of Adenomyosis Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis Levonorgestrel Intrauterine System and Adenomyosis Validation of the Adenomyosis Calculator Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer. New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms High-intensity Focused Ultrasound in Treatment of Uterine Adenomyosis Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis Norwegian Adenomyosis Study III: Peristalsis Histopathological Diagnosis of Adenomyosis Norwegian Adenomyosis Study I Vaginal Bromocriptine for Treatment of Adenomyosis Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis

Brief Title

Observational Study of Patients Suffering From Endometriosis and Adenomyosis

Official Title

Prospective Long Term Observational Study of Health Profile, Clinical Characteristics and Outcome of Patients Suffering From Endometriosis and Adenomyosis

Brief Summary

      Endometriosis and adenomyosis are chronic difficult diseases affecting a significant
      proportion of reproductive age women. it is hoped that the investigators can collect the
      health profile of these participants using structured questionnaires on their quality of
      life, reproductive health, collect the sonographic characteristics, identify the risks
      factors of participants suffering from severe disease, and to propose the best treatment
      modality for different patient groups, both with and without fertility wish.

Detailed Description

      Endometriosis and adenomyosis are chronic difficult diseases affecting a significant
      proportion of reproductive age women. Not only the disease can lead to chronic pelvic pain,
      dyspareunia and dysmenorrhea, it is also associated with impaired reproductive health,
      infertility and tubal-peritoneal disease. Adenomyosis can also result in anaemia due to the
      increased uterine volume and menstrual blood loss. Different treatment options are available
      for this group of participants, ranging from simple medical treatment to control symptoms,
      such as analgesics for pain control, transexemic acid to reduce menstrual blood loss, to
      hormonal treatment and the more radical surgical treatment.

      As a tertiary gynaecology referral centre, the investigators encounter a large volume of
      patients suffering from endometriosis and adenomyosis of different disease severity. Through
      this prospective observational study, it is hoped that the investigators can collect the
      health profile of participants using structured questionnaires on their quality of life,
      reproductive health, collect the sonographic characteristics, identify the risks factors of
      patients suffering from severe disease, and to propose the best treatment modality for
      different participant groups, both with and without fertility wish.

      Patients attending the pelvic mass clinic/ endometriosis clinic with the histologically
      confirmed or sonographic evidence of endometriosis/ adenomyosis will be invited to
      participate in the prospective study. Their demographic data will be collected.
      Symptomatology and health profile will be collected via questionnaires (e.g.EHP-30, SF 36,
      FSFI) to evaluate the physical, psychological, sexual and social aspects of patients
      affecting by the disease. Menstrual chart with be recorded. Physical examination including
      abdominal and pelvic examination will be performed. Pelvic sonography will be offered and
      recorded systematically. Different medical/ surgical treatments will be offered based on
      patient's clinical condition in an evidence-based approach and clinical guidance. Their
      treatment outcome will be assessed during the follow-up. Surgical findings will be recorded
      and disease severity graded by use of AFS scores. Pathological findings will be evaluated.

Study Type

Observational

Primary Outcome

Endometriosis Health Profile (EHP-30) questionnaire score

Secondary Outcome

 side effects profile of medical treatment

Condition

Endometriosis

Study Arms / Comparison Groups

 Endometriosis or adenomyosis
Description:  participants suffering pelvic endometriosis, endometrioma, deep infiltrating endometriosis or adenomyosis

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Estimated Enrollment

880

Start Date

April 30, 2021

Completion Date

December 31, 2032

Primary Completion Date

December 31, 2031

Eligibility Criteria

        Inclusion Criteria:

          -  with endometriosis or adenomyosis confirmed by ultrasound or MRI

        Exclusion Criteria:

          -  refuse to participate in the study, less than 18 years old, menopausal, illiterate or
             mentally incapable

Gender

Female

Ages

18 Years - N/A

Contacts

Wen Ying Linda FUNG, (852) 55699192, [email protected]

Location Countries

Hong Kong

Location Countries

Hong Kong

Administrative Informations

NCT ID

NCT04862000

Organization ID

CRE 2020.688

Responsible Party

Principal Investigator

Study Sponsor

Chinese University of Hong Kong

Study Sponsor

Wen Ying Linda FUNG, Principal Investigator, Chinese University of Hong Kong

Verification Date

July 2022